Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation

被引:26
作者
Chen, Yajing [1 ]
Wu, Tingting [1 ]
Li, Heng [2 ]
Li, Xuan [1 ]
Li, Qing [3 ,4 ]
Zhu, Xiaoying [1 ]
Yu, Mei [3 ,4 ]
Kuo, Sheng-Han [5 ]
Huang, Fang [3 ,4 ]
Wu, Yun-Cheng [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Neurol, Shanghai, Peoples R China
[2] Shandong Univ, Jinan Cent Hosp, Dept Neurol, Jinan, Shandong, Peoples R China
[3] Fudan Univ, Shanghai Med Coll, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai, Peoples R China
[4] Fudan Univ, Shanghai Med Coll, Collaborat Innovat Ctr Brain Sci, Shanghai, Peoples R China
[5] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA
来源
FRONTIERS IN AGING NEUROSCIENCE | 2019年 / 11卷
基金
中国国家自然科学基金;
关键词
dl-3-n-butylphthalide; MAPK; microglia; neuroinflammation; NF-kappa B; Parkinson's disease; NF-KAPPA-B; PARKINSONS-DISEASE; MOUSE MODEL; ALZHEIMERS-DISEASE; NEURONS; ACTIVATION; MICROGLIA; INJURY; BRAIN; INFLAMMATION;
D O I
10.3389/fnagi.2019.00044
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Microglia-mediated neuroinflammation contributes to multiple neurodegenerative disorders, including PD. Therefore, the regulation of microglial activation probably has the therapeutic potential. This study is aimed to determine whether NBP could suppress microglial activation and protect dopaminergic neurons from excessive neuroinflammation. In the present study, MPTP-induced PD model was established to explore the neuroprotective and anti-inflammatory effect of NBP. We assessed motor deficits, dopaminergic neurodegeneration and microglial activation in PD mice. In vitro, the anti-inflammatory activity of NBP was confirmed by cell viability assay of SH-SY5Y cells after being treated with conditioned medium from LPS-stimulated BV-2 cells and from 1-Methyl-4-phenylpyridinium iodide (MPP+)-stimulated BV-2 cells. The expression of pro-inflammatory molecules was determined by RT-PCR, Western Blot and ELISA assay. The generation of NO and ROS were also assessed. The involvement of signaling pathways such as MAPK, NF-kappa B, and PI3k/Akt were further investigated by Western Blot and immunofluorescence assay. The neuroprotective effect of NBP was demonstrated in vivo as shown by the improvement of dopaminergic neurodegeneration, motor deficits and microglial activation in MPTP-induced mouse model of PD. The expression of pro-inflammatory mediators was also reduced by NBP administration. In vitro, NBP also protected dopaminergic neurons from neurotoxicity induced by activated microglia. NBP pretreatment not only reduced pro-inflammatory molecules, but also suppressed NO release and ROS generation in BV-2 cells. Further mechanism research suggested that the inactivation of MAPK, NF-kappa B and PI3K/Akt may involve in anti-neuroinflammation role of NBP. In conclusion, our results revealed that NBP exerted dopaminergic neuroprotection through inhibition of microglia-mediated neuroinflammation, suggesting the promising therapeutic effect of NBP for PD.
引用
收藏
页数:17
相关论文
共 48 条
  • [1] Animal behavioral assessments in current research of Parkinson's disease
    Asakawa, Tetsuya
    Fang, Huan
    Sugiyama, Kenji
    Nozaki, Takao
    Hong, Zhen
    Yang, Yilin
    Hua, Fei
    Ding, Guanghong
    Chao, Dongman
    Fenoy, Albert J.
    Villarreal, Sebastian J.
    Onoe, Hirotaka
    Suzuki, Katsuaki
    Mori, Norio
    Namba, Hiroki
    Xia, Ying
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2016, 65 : 63 - 94
  • [2] The ongoing pursuit of neuroprotective therapies in Parkinson disease
    Athauda, Dilan
    Foltynie, Thomas
    [J]. NATURE REVIEWS NEUROLOGY, 2015, 11 (01) : 25 - 40
  • [3] Rice bran derivatives alleviate microglia activation: possible involvement of MAPK pathway
    Bhatia, Harsharan S.
    Baron, Julian
    Hagl, Stephanie
    Eckert, Gunter P.
    Fiebich, Bernd L.
    [J]. JOURNAL OF NEUROINFLAMMATION, 2016, 13
  • [4] The involvement of NF-κB p65/p52 in the effects of GDNF on DA neurons in early PD rats
    Cao, Jun Ping
    Wang, Hong Jun
    Yu, Jing Kao
    Liu, Hong Mei
    Gao, Dian Shuai
    [J]. BRAIN RESEARCH BULLETIN, 2008, 76 (05) : 505 - 511
  • [5] DL-3-n-butylphthalide reduces microglial activation in lipopolysaccharide-induced Parkinson's disease model mice
    Chen, Yuhua
    Jiang, Mujun
    Li, Li
    Ye, Ming
    Yu, Meiling
    Zhang, Lina
    Ge, Bobo
    Xu, Wenfang
    Wei, Daoxiang
    [J]. MOLECULAR MEDICINE REPORTS, 2018, 17 (03) : 3884 - 3890
  • [6] Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition
    Croisier, Emilie
    Moran, Linda B.
    Dexter, David T.
    Pearce, Ronald K. B.
    Graeber, Manuel B.
    [J]. JOURNAL OF NEUROINFLAMMATION, 2005, 2 (1)
  • [7] The substantia nigra of the human brain - II. Patterns of loss of dopamine-containing neurons in Parkinson's disease
    Damier, P
    Hirsch, EC
    Agid, Y
    Graybiel, AM
    [J]. BRAIN, 1999, 122 : 1437 - 1448
  • [8] Microglia, Amyloid, and Glucose Metabolism in Parkinson's Disease with and without Dementia
    Edison, Paul
    Ahmed, Imtiaz
    Fan, Zhen
    Hinz, Rainer
    Gelosa, Giorgio
    Chaudhuri, K. Ray
    Walker, Zuzana
    Turkheimer, Federico E.
    Brooks, David J.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2013, 38 (06) : 938 - 949
  • [9] DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis
    Feng, Xinhong
    Peng, Ying
    Liu, Mingsheng
    Cui, Liying
    [J]. NEUROPHARMACOLOGY, 2012, 62 (02) : 1004 - 1010
  • [10] Anti-inflammatory drugs and risk of Parkinson disease A meta-analysis
    Gagne, Joshua J.
    Power, Melinda C.
    [J]. NEUROLOGY, 2010, 74 (12) : 995 - 1002